Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion type Assertion NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_head.
- NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion description "[Methylation of PRDM5 was detected in 6.6% (4 of 61) of primary colorectal and 50.0% (39 of 78) of primary gastric cancers but not in noncancerous tissue samples collected from areas adjacent to the tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_provenance.
- NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion evidence source_evidence_literature NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_provenance.
- NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion SIO_000772 17699856 NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_provenance.
- NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion wasDerivedFrom befree-20140225 NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_provenance.
- NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_assertion wasGeneratedBy ECO_0000203 NP517398.RAd1znvjZG-NaxAxNm6nOKms-mInC59FOTg1wxF8zLrGU130_provenance.